Home › Crohn's Disease › New Jersey
Crohn's Disease clinical trials in New Jersey
9 studies for Crohn's Disease are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- HMH Justice Marie Garibaldi Medical Plaza ( Site 5072), Hackensack
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Sep 29, 2026 · NCT06430801A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Goryeb Children's Hospital, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 25, 2026 · NCT05923073An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Sanmora Bespoke Clinical Research Solutions LLC-Site Number: 8400123, East Orange
- Allied Health Clinical Research Organization, LLC - Freehold-Site Number: 8400014, Freehold
- Tandem-Allied Clinical Research - Somers Point-Site Number: 8400050, Somers Point
- and 1 more
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Goryeb Childrens Hospital /ID# 256452, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 23, 2026 · NCT05995353Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Atlantic Children's Health--Pediatric Gastroenterology, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Aug 24, 2026 · NCT05509777A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Atlantic Health - Morristown Medical Center, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Jun 22, 2026 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Goryeb Children's Hospital/Morristown Medical Center/Atlantic Children's Health, Morristown
RecruitingPhase 4
Ages 6 to 17 · All sexes · Updated May 27, 2026 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Goryeb Children's Hospital, Morristown
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated May 5, 2026 · NCT04779320From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.